The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Neutrophils in Cancer: Two Sides of the Same Coin
Open accessAbstract
Neutrophils are the most abundant leukocytes in blood and are considered to be the first line of defense during inflammation and infections. In addition, neutrophils are also found infiltrating many types of tumors. Tumor-associated neutrophils (TANs) have relevant roles in malignant disease. Indeed neutrophils may be potent antitumor effector cells. However, increasing clinical evidence shows TANs correlate with poor prognosis. The tumor microenvironment controls neutrophil recruitment and in turn TANs help tumor progression. Hence, TANs can be beneficial or detrimental to the host. It is the purpose of this review to highlight these two sides of the neutrophil coin in cancer and to describe recent studies that provide some light on the mechanisms for neutrophil recruitment to the tumor, for neutrophils supporting tumor progression, and for neutrophil activation to enhance their antitumor functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Templeton, A. J., McNamara, M. G., Šeruga, B., Vera-Badillo, F. E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J. J., Tran, B., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju124 · Cited by 2,829
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797 · cited 1×
“MMP-9 reduced the angiogenic switching, tumor number, and tumor growth [109], indicating that MMP-9 can render”
BackgroundCirculating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Segal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,789
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Neutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,573
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174
Neutrophil serine proteases: specific regulators of inflammation
Pham, C. T. N. (2006) · Nature Reviews Immunology · doi:10.1038/nri1841 · Cited by 1,022
Neutrophil extracellular traps: Is immunity the second function of chromatin?
Brinkmann, V., & Zychlinsky, A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201203170 · Cited by 1,021
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918
The molecular architecture of the TNF superfamily
Bodmer, J.-L., Schneider, P., & Tschopp, J. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01995-8 · Cited by 916
Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
Walsh, S. R., Cook, E. J., Goulder, F., Justin, T. A., & Keeling, N. J. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20329 · Cited by 894
Demers, M., Krause, D. S., Schatzberg, D., Martinod, K., Voorhees, J. R., Fuchs, T. A., Scadden, D. T., & Wagner, D. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200419109 · Cited by 883
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Sagiv, J. Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., Damti, P., Lumbroso, D., Polyansky, L., Sionov, R. V., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.039 · Cited by 816
The neutrophil as a cellular source of chemokines
Scapini, P., Lapinet‐Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., & Cassatella, M. A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17706.x · Cited by 802
Tumor entrained neutrophils inhibit seeding in the premetastatic lung
Granot, Z., Henke, E., Comen, E. A., King, T. A., Norton, L., & Benezra, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.012 · Cited by 782
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., Stolz, D. B., Land, S. R., Marconcini, L. A., Kliment, C. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2084 · Cited by 744
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & McGarry Houghton, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 707
Giraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700
Neutrophil-derived cytokines: facts beyond expression
Tecchio, C., Micheletti, A., & Cassatella, M. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00508 · Cited by 699
Tumor-associated neutrophils: friend or foe?
Fridlender, Z. G., & Albelda, S. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs123 · Cited by 699
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015855107 · Cited by 663
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 650
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Bodmer, J.-L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000) · Nature Cell Biology · doi:10.1038/35008667 · Cited by 649
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77053 · Cited by 644
NETs: a new strategy for using old weapons
Papayannopoulos, V., & Zychlinsky, A. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.011 · Cited by 634 · cited 1×
“Bacterial products such as lipo polysaccharide (LPS), formyl-methionyl-leucyl-phenylalanine (fMLF), and also phorbol esters such as phorbol myristate acetate (PMA) are efficient NET inducers [200].”
BackgroundMyeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630
Wu, P., Wu, D., Ni, C., Ye, J., Chen, W., Hu, G., Wang, Z., Wang, C., Zhang, Z., Xia, W., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.013 · Cited by 608
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Lechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wang, W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00368 · Cited by 567
The significance of hematogenous tumor cell clumps in the metastatic process.
Liotta, L. A., Saidel, M. G., & Kleinerman, J. I. (1976) · PubMed · Cited by 567
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
The role of chemokines in neutrophil biology
Kobayashi, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2853 · Cited by 545
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., & López-Otín, C. (2003) · Nature Genetics · doi:10.1038/ng1249 · Cited by 536
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Korkmaz, B., Moreau, T., & Gauthier, F. (2008) · Biochimie · doi:10.1016/j.biochi.2007.10.009 · Cited by 480
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Tumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440
Deryugina, E. I., & Quigley, J. P. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.04.004 · Cited by 422
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment
Sionov, R. V., Fridlender, Z. G., & Granot, Z. (2015) · Cancer Microenvironment · doi:10.1007/s12307-014-0147-5 · Cited by 416
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., & Jorcyk, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1734 · Cited by 413
De Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412
Halazun, K. J., Hardy, M. A., Rana, A. A., Woodland, D. C., Luyten, E. J., Mahadev, S., Witkowski, P., Siegel, A. B., Brown, R. S., & Emond, J. C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a77e59 · Cited by 401
Gupta, A. K., Hasler, P., Holzgreve, W., Gebhardt, S., & Hahn, S. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.11.003 · Cited by 401
Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells
Spicer, J. D., McDonald, B., Cools-Lartigue, J. J., Chow, S. C., Giannias, B., Kubes, P., & Ferri, L. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2393 · Cited by 401
Dumitru, C. A., Moses, K., Trellakis, S., Lang, S., & Brandau, S. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1294-5 · Cited by 374
Yan, H. H., Pickup, M., Pang, Y., Gorska, A. E., Li, Z., Chytil, A., Geng, Y., Gray, J. W., Moses, H. L., & Yang, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0706 · Cited by 372
Huang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X.-D., Gudas, J. M., & Bar-Eli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64164-8 · Cited by 361
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., & Fridlender, Z. G. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1476-9 · Cited by 356
Huh, S. J., Liang, S., Sharma, A., Dong, C., & Robertson, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4442 · Cited by 352
Inhibition of tumor growth by elimination of granulocytes.
Pekarek, L. A., Starr, B. A., Toledano, A. Y., & Schreiber, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.435 · Cited by 340
Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I. J., Larsen, S., Gehl, J., & von der Maase, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602702 · Cited by 329
Molecular mechanisms regulating NETosis in infection and disease
Branzk, N., & Papayannopoulos, V. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0384-6 · Cited by 316
Paramanathan, A., Saxena, A., & Morris, D. L. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2013.12.001 · Cited by 316
Neutrophils efficiently cross-prime naive T cells in vivo
Beauvillain, C., Delneste, Y., Scotet, M., Peres, A., Gascan, H., Guermonprez, P., Barnaba, V., & Jeannin, P. (2007) · Blood · doi:10.1182/blood-2006-12-063826 · Cited by 315
Brandau, S., Trellakis, S., Bruderek, K., Schmaltz, D., Steller, G., Elian, M., Suttmann, H., Schenck, M., Welling, J., Zabel, P., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310162 · Cited by 315
Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031524 · Cited by 311
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., & Quigley, J. P. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.013 · Cited by 304
Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.031 · Cited by 298
Raber, P. L., Thevenot, P., Sierra, R., Wyczechowska, D., Halle, D., Ramirez, M. E., Ochoa, A. C., Fletcher, M., Velasco, C., Wilk, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28622 · Cited by 297
Neutrophil Extracellular Traps: How to Generate and Visualize Them
Brinkmann, V., Laube, B., Abu Abed, U., Goosmann, C., & Zychlinsky, A. (2010) · Journal of Visualized Experiments · doi:10.3791/1724 · Cited by 291
Genotoxic effects of neutrophils and hypochlorous acid
Gungor, N., Knaapen, A. M., Munnia, A., Peluso, M., Haenen, G. R., Chiu, R. K., Godschalk, R. W. L., & van Schooten, F. J. (2010) · Mutagenesis · doi:10.1093/mutage/gep053 · Cited by 291
A proposed role for neutrophil extracellular traps in cancer immunoediting
Berger-Achituv, S., Brinkmann, V., Abed, U. A., Kühn, L. I., Ben-Ezra, J., Elhasid, R., & Zychlinsky, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00048 · Cited by 288
Krenn-Pilko, S., Langsenlehner, U., Thurner, E.-M., Stojakovic, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.163 · Cited by 281
Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
K-ras activation generates an inflammatory response in lung tumors
Ji, H., Houghton, A. M., Mariani, T. J., Perera, S., Kim, C. B., Padera, R., Tonon, G., McNamara, K., Marconcini, L. A., Hezel, A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209237 · Cited by 271
Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps
von Köckritz-Blickwede, M., & Nizet, V. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0481-0 · Cited by 270
Behnen, M., Leschczyk, C., Möller, S., Batel, T., Klinger, M., Solbach, W., & Laskay, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400478 · Cited by 255
Mishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S. M., Granot, Z., & Fridlender, Z. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28770 · Cited by 253
Waight, J. D., Hu, Q., Miller, A., Liu, S., & Abrams, S. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027690 · Cited by 246
Sun, Z., & Yang, P. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01414-7 · Cited by 244
Wislez, M., Rabbe, N., Marchal-Sommé, J., Milleron, B. J., Crestani, B., Mayaud, C. M., Antoine, M., Soler, P., & Cadranel, J. L. (2003) · PubMed · Cited by 243
Bellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bernaudin, J., Mayaud, C. M., Milleron, B. J., Baud, L., & Cadranel, J. L. (1998) · PubMed Central · Cited by 228
Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils
Kousis, P. C., Henderson, B. W., Maier, P. G., & Gollnick, S. O. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1778 · Cited by 224
Schneider-Merck, T., Lammerts van Bueren, J. J., Berger, S., Rossen, K., van Berkel, P. H. C., Derer, S., Beyer, T., Lohse, S., Bleeker, W. K., Peipp, M., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900847 · Cited by 222
Neutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
Suttmann, H., Riemensberger, J., Bentien, G., Schmaltz, D., Stöckle, M., Jocham, D., Böhle, A., & Brandau, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1416 · Cited by 212
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
Hawinkels, L. J. A. C., Zuidwijk, K., Verspaget, H. W., de Jonge-Muller, E. S. M., Duijn, W. V., Ferreira, V., Fontijn, R. D., David, G., Hommes, D. W., Lamers, C. B. H. W., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.031 · Cited by 211
Ogata, Y., Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18506 · Cited by 201
He, J., Shen, G., Ren, Z., Qin, H., Cui, C., Zhang, Y., Zeng, Y., & Jia, W. (2012) · Head & Neck · doi:10.1002/hed.22008 · Cited by 201
Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2502 · Cited by 200
IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer
Rotondo, R., Barisione, G., Mastracci, L., Grossi, F., Orengo, A. M., Costa, R., Truini, M., Fabbi, M., Ferrini, S., & Barbieri, O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24448 · Cited by 198
Sippel, T. R., White, J., Nag, K., Tsvankin, V., Klaassen, M., Kleinschmidt-DeMasters, B. K., & Waziri, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1107 · Cited by 195
Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., & Inferrera, C. (2002) · Modern Pathology · doi:10.1097/01.mp.0000020391.98998.6b · Cited by 194
On the cytokines produced by human neutrophils in tumors
Tecchio, C., Scapini, P., Pizzolo, G., & Cassatella, M. A. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.004 · Cited by 188
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
Ludwig, A. T., Moore, J. M., Luo, Y., Chen, X., Saltsgaver, N. A., O’Donnell, M. A., & Griffith, T. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0374 · Cited by 186
Neutrophils and respiratory tract DNA damage and mutagenesis: a review
Knaapen, A. M. (2006) · Mutagenesis · doi:10.1093/mutage/gel032 · Cited by 186
Masson, V., De La Ballina, L. R., Munaut, C., Wielockx, B., Jost, M., Maillard, C., Blacher, S., Bajou, K., Itoh, T., Itohara, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2140fje · Cited by 183
Martínez-Lorenzo, M. J., Alava, M. A., Gamen, S., Kim, K. J., Chuntharapai, A., Piñeiro, A., Naval, J., & Anel, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2714::aid-immu2714>3.0.co;2-9 · Cited by 183
Tazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., Sendo, F., Kobayashi, M., & Hosokawa, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63580-8 · Cited by 178
Tumor-infiltrating neutrophils in pancreatic neoplasia
Reid, M. D., Basturk, O., Thirabanjasak, D., Hruban, R. H., Klimstra, D. S., Bagci, P., Altinel, D., & Adsay, V. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.113 · Cited by 177
Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe?
Cooper, P. R., Palmer, L. J., & Chapple, I. L. C. (2013) · Periodontology 2000 · doi:10.1111/prd.12025 · Cited by 172
Loukinova, E., Dong, G., Enamorado-Ayalya, I., Thomas, G. R., Chen, Z., Schreiber, H., & Van Waes, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203687 · Cited by 172
Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8
Schaider, H., Oka, M., Bogenrieder, T., Nesbit, M., Satyamoorthy, K., Berking, C., Matsushima, K., & Herlyn, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10775 · Cited by 169
Valerius, T., Repp, R., de Wit, T., Berthold, S., Platzer, E., Kalden, Jr., Gramatzki, M., & van de Winkel, J. (1993) · Blood · doi:10.1182/blood.v82.3.931.931 · Cited by 165
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice
Hicks, A. M., Riedlinger, G., Willingham, M. C., Alexander-Miller, M. A., Von Kap-Herr, C., Pettenati, M. J., Sanders, A. M., Weir, H. M., Du, W., Kim, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602382103 · Cited by 165
Oxidation of Cofilin Mediates T Cell Hyporesponsiveness under Oxidative Stress Conditions
Klemke, M., Wabnitz, G. H., Funke, F., Funk, B., Kirchgessner, H., & Samstag, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.016 · Cited by 162
Welch, D. R., Schissel, D. J., Howrey, R. P., & Aeed, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5859 · Cited by 161
Ardi, V. C., den Steen, P. E. V., Opdenakker, G., Schweighofer, B., Deryugina, E. I., & Quigley, J. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033472 · Cited by 161
Brandau, S., Moses, K., & Lang, S. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.007 · Cited by 159
Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., & DeClerck, Y. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3770 · Cited by 159
Protumor and antitumor functions of neutrophil granulocytes
Brandau, S., Dumitru, C. A., & Lang, S. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0344-6 · Cited by 158
Malmberg, K., Arulampalam, V., Ichihara, F., Petersson, M., Seki, K., Andersson, T., Lenkei, R., Masucci, G. V., Pettersson, S., & Kiessling, R. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2595 · Cited by 150
Raychaudhuri, B., Rayman, P. A., Huang, P., Grabowski, M. M., Hambardzumyan, D., Finke, J. H., & Vogelbaum, M. A. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1720-6 · Cited by 148
López-Lago, M. A., Posner, S., Thodima, V. J., Molina, A. M., Motzer, R. J., & Chaganti, R. S. K. (2012) · Oncogene · doi:10.1038/onc.2012.201 · Cited by 146
Neutrophils promote motility of cancer cells via a hyaluronan‐mediated TLR4/PI3K activation loop
Wu, Y., Zhao, Q., Peng, C., Sun, L., Li, X., & Kuang, D. (2011) · The Journal of Pathology · doi:10.1002/path.2947 · Cited by 146
Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bánkfalvi, Á., Whiteside, T. L., Lang, S., & Brandau, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25991 · Cited by 146
Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases
Chantrain, C. F., Henriet, P., Jodele, S., Emonard, H., Féron, O., Courtoy, P. J., DeClerck, Y. A., & Marbaix, É. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.010 · Cited by 144
Aleyd, E., van Hout, M. W. M., Ganzevles, S. H., Hoeben, K. A., Everts, V. E., Bakema, J. E., & van Egmond, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300261 · Cited by 144
Crissman, J. D., Hatfield, J. S., Schaldenbrand, M. F., Sloane, B. F., & Honn, K. V. (1985) · PubMed · Cited by 142
Sangaletti, S., Tripodo, C., Vitali, C., Portararo, P., Guarnotta, C., Casalini, P., Cappetti, B., Miotti, S., Pinciroli, P., Fuligni, F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0276 · Cited by 139
Rotondo, R., Bertolotto, M. B., Barisione, G., Astigiano, S., Mandruzzato, S., Ottonello, L. C., Dallegri, F., Bronte, V., Ferrini, S., & Barbieri, O. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109737 · Cited by 139
Malietzis, G. A., Giacometti, M., Kennedy, R. H., Athanasiou, T., Aziz, O., & Jenkins, J. T. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3815-2 · Cited by 137
Neutrophils as effector cells for antibody-based immunotherapy of cancer
van Egmond, M., & Bakema, J. E. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.12.002 · Cited by 136
Human neutrophils facilitate tumor cell transendothelial migration
Wu, Q. D., Wang, J. H., Condron, C. M., Bouchier‐Hayes, D. M., & Redmond, H. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c814 · Cited by 135
Peng, B., Wang, Y., Liu, Y., & Ma, L.-X. (2015) · Europe PMC (PubMed Central) · Cited by 134
Neutrophil elastase and cancer
Sato, T., Takahashi, S., Mizumoto, T., Harao, M., Akizuki, M., Takasugi, M., Fukutomi, T., & Yamashita, J. (2006) · Surgical Oncology · doi:10.1016/j.suronc.2007.01.003 · Cited by 131
Kemp, T. J., Ludwig, A. T., Earel, J. K., Moore, J. M., VanOosten, R. L., Moses, B., Leidal, K. G., Nauseef, W. M., & Griffith, T. S. (2005) · Blood · doi:10.1182/blood-2005-03-1327 · Cited by 129
Pistelli, M., Lisa, M. D., Ballatore, Z., Caramanti, M., Pagliacci, A., Battelli, N., Ridolfi, F., Santoni, M., Maccaroni, E., Bracci, R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1204-2 · Cited by 124
Ebrahem, Q., Chaurasia, S. S., Vasanji, A., Qi, J. H., Klenotic, P. A., Cutler, A., Asosingh, K., ERZURUM, S. C., & Anand‐Apte, B. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.080642 · Cited by 123
IgA EGFR antibodies mediate tumour killing in vivo
Boross, P., Lohse, S., Nederend, M., Jansen, J. H. M., van Tetering, G., Dechant, M., Peipp, M., Royle, L., Liew, L. P., Boon, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201929 · Cited by 118
Grenier, A., Chollet‐Martin, S., Crestani, B., Delarche, C., Benna, J. E., Boutten, A., Andrieu, V., Durand, G., Gougerot‐Pocidalo, M., Aubier, M., et al. (2002) · Blood · doi:10.1182/blood.v99.8.2997 · Cited by 115
Favaloro, J., Liyadipitiya, T., Brown, R. D., Yang, S., Suen, H., Woodland, N., Nassif, N. T., Hart, D. N. J., Fromm, P. D., Weatherburn, C., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.904511 · Cited by 113
Alemán, O. R., Mora, N., Cortés-Vieyra, R., Uribe‐Querol, E., & Rosales, C. (2016) · Journal of Immunology Research · doi:10.1155/2016/2908034 · Cited by 113
Self-citationWada, Y., Yoshida, K., Tsutani, Y., Shigematsu, H., Oeda, M., Sanada, Y., Suzuki, T., Mizuiri, H., Hamai, Y., Tanabe, K., et al. (2007) · Oncology Reports · doi:10.3892/or.17.1.161 · Cited by 112
Shabani, F., McNeil, J., & Tippett, L. (1998) · Free Radical Research · doi:10.3109/10715769809065797 · Cited by 108
Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer
Cullen, S. P., & Martin, S. J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.01.012 · Cited by 102
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells
Yan, J., Kloecker, G. H., Fleming, C., Bousamra, M., Hansen, R., Hu, X., Ding, C., Cai, Y., Xiang, D., Donninger, H., et al. (2014) · OncoImmunology · doi:10.4161/15384101.2014.950163 · Cited by 98
Myeloid cell population dynamics in healthy and tumor-bearing mice
Ueha, S., Shand, F. H. W., & Matsushima, K. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.03.003 · Cited by 97
Bakema, J. E., & van Egmond, M. (2011) · mAbs · doi:10.4161/mabs.3.4.16092 · Cited by 96
Trellakis, S., Bruderek, K., Hütte, J., Elian, M., Hoffmann, T. K., Lang, S., & Brandau, S. (2012) · Innate Immunity · doi:10.1177/1753425912463618 · Cited by 96
Neutrophils influence melanoma adhesion and migration under flow conditions
Slattery, M. J., & Dong, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11297 · Cited by 95
Deryugina, E. I., Zijlstra, A., Partridge, J. J., Kupriyanova, T. A., Madsen, M. A., Papagiannakopoulos, T. Y., & Quigley, J. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2228 · Cited by 94
Therapeutic applications of TRAIL receptor agonists in cancer and beyond
Amarante-Mendes, G. P., & Griffith, T. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.09.001 · Cited by 89
Colombo, M. P., Lombardi, L., Stoppacciaro, A., Melani, C. C., Parenza, M., Bottazzi, B., & Parmiani, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.113 · Cited by 88
Wilson, T. J., Nannuru, K. C., Futakuchi, M., & Singh, R. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.035 · Cited by 87
Strell, C., Lang, K., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.003 · Cited by 85
Okabe, H., Beppu, T., Ueda, M., Hayashi, H., Ishiko, T., Masuda, T., Otao, R., Horlad, H., Mima, K., Miyake, K., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27496 · Cited by 85
Human CD4 + FOXP3 + regulatory T cells produce CXCL8 and recruit neutrophils
Himmel, M. E., Crome, S. Q., Ivison, S. M., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2010) · European Journal of Immunology · doi:10.1002/eji.201040459 · Cited by 85
Human Neutrophil-Mediated Cytotoxicity to Tumor Cells 2 3
Gerrard, T. L., Cohen, D., & Kaplan, A. M. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/66.3.483 · Cited by 84
Gaida, M. M., Steffen, T., Günther, F. A., Tschaharganeh, D. F., Felix, K., Bergmann, F., Schirmacher, P., & Hänsch, G. M. (2012) · European Journal of Immunology · doi:10.1002/eji.201242628 · Cited by 83
Tumor Angiogenesis Induced by Granulocyte Chemotactic Protein-2 as a Countercurrent Principle
Coillie, E. V., Aelst, I. V., Wuyts, A., Vercauteren, R., Devos, R., Wolf‐Peeters, C. D., Damme, J. V., & Opdenakker, G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62527-8 · Cited by 83
Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy
Bakema, J. E., Ganzevles, S. H., Fluitsma, D. M., Schilham, M. W., Beelen, R. H. J., Valerius, T., Lohse, S., Glennie, M. J., Medema, J. P., & van Egmond, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002581 · Cited by 82
Dong, C., Slattery, M. J., Liang, S., & Peng, H. (2005) · PubMed · Cited by 76
Secretion of oncostatin M by neutrophils in rheumatoid arthritis
Cross, A. L., Edwards, S. W., Bucknall, R. C., & Moots, R. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20166 · Cited by 76
Wabnitz, G. H., Goursot, C., Jahraus, B., Kirchgessner, H., Hellwig, A., Klemke, M., Konstandin, M. H., & Samstag, Y. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.36 · Cited by 75
Choi, J., Suh, B., Ahn, Y., Kim, T. M., Lee, J., Lee, S., & Heo, D. S. (2011) · Tumor Biology · doi:10.1007/s13277-011-0254-6 · Cited by 73
Dallegri, F., Ottonello, L. C., Ballestrero, A., Dapino, P., Ferrando, F., Patrone, F., & Sacchetti, C. A. S. (1991) · Inflammation · doi:10.1007/bf00917906 · Cited by 73
Aeed, P. A., Nakajima, M., & Welch, D. R. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420521 · Cited by 72
Polymorphonuclear Granulocytes Induce Antibody-Dependent Apoptosis in Human Breast Cancer Cells
Stockmeyer, B., Beyer, T. D., Neuhuber, W., Repp, R., Kalden, J. R., Valerius, T., & i, M. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5124 · Cited by 69
Wilson, T. J., Nannuru, K. C., & Singh, R. K. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0028 · Cited by 69
Fc receptors: Cell activators of antibody functions
Rosales, C., & Uribe‐Querol, E. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.44a004 · Cited by 68
Self-citationOncostatin M Production by Blood and Alveolar Neutrophils during Acute Lung Injury
Grenier, A., Combaux, D., Chastre, J. E., Gougerot-Pocidalo, M. A., Gibert, C., Dehoux, M., & Chollet‐Martin, S. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780220 · Cited by 66
Evaluation of a series of bicyclic CXCR2 antagonists
Walters, I. A. S., Austin, C. A., Austin, R. P., Bonnert, R. V., Cage, P. A., Christie, M. I., Ebden, M. R., Gardiner, S. D., Grahames, C., Hill, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.039 · Cited by 63
Cytotoxic Effects of Peritoneal Neutrophils on a Syngeneic Rat Tumour
PICKAVER, A. H., Ratcliffe, N. A., WILLIAMS, A. E., & Smith, H. C. (1972) · Nature New Biology · doi:10.1038/newbio235186a0 · Cited by 62
Goren, I., Kämpfer, H., Müller, E., Schiefelbein, D., Pfeilschifter, J. M., & Frank, S. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700136 · Cited by 61
Derer, S., Glorius, P., Schlaeth, M., Lohse, S., Klausz, K., Muchhal, U. S., Desjarlais, J. R., Humpe, A., Valerius, T., & Peipp, M. (2013) · mAbs · doi:10.4161/mabs.27457 · Cited by 61
A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer
Dumitru, C. A., Fechner, M. K., Hoffmann, T. K., Lang, S., & Brandau, S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411193 · Cited by 61
Natural killer cells: The journey from puzzles in biology to treatment of cancer
Bodduluru, L. N., Kasala, E. R., Madhana, R. M., & Sriram, C. S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.020 · Cited by 61
Novel role of regulatory T cells in limiting early neutrophil responses in skin
Richards, H. E., Williams, A. S., Jones, E., Hindley, J. P., Godkin, A. J., Simon, A. K., & Gallimore, A. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03333.x · Cited by 60
Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis
Verbeke, H., Struyf, S., Berghmans, N., Coillie, E. V., Opdenakker, G., Uyttenhove, C., Snick, J. V., & Damme, J. V. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.12.013 · Cited by 59
Clathrin Pit-mediated Endocytosis of Neutrophil Elastase and Cathepsin G by Cancer Cells
Gregory, A. D., Hale, P. D., Perlmutter, D. H., & Houghton, A. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385617 · Cited by 59
Wada, Y., Yoshida, K., Hihara, J., Konishi, K., Tanabe, K., Ukon, K., Taomoto, J., Suzuki, T., & Mizuiri, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00278.x · Cited by 55
Short, K. R., von Köckritz‐Blickwede, M., Langereis, J. D., Chew, K. Y., Job, E. R., Armitage, C. W., Hatcher, B., Fujihashi, K., Reading, P. C., Hermans, P. W. M., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01104-13 · Cited by 55
Aruga, A., Aruga, E., Cameron, M. J., & Chang, A. E. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.4.507 · Cited by 55
Clynes, R. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.02.010 · Cited by 54
Rosevear, H. M., Lightfoot, A. J., O’Donnell, M. A., & Griffith, T. S. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9195-6 · Cited by 54
Krenn-Pilko, S., Langsenlehner, U., Stojaković, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T. (2015) · Tumor Biology · doi:10.1007/s13277-015-3805-4 · Cited by 50
PMN and anti-tumor immunity—The case of bladder cancer immunotherapy
Brincks, E. L., Risk, M. C., & Griffith, T. S. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.002 · Cited by 44
Atzpodien, J., & Reitz, M. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0429 · Cited by 43
Oxidative burst and anticancer activities of rat neutrophils
Živković, M., Poljak‐Blaži, M., Egger, G., Šunjić, S. B., Schaur, R. J., & Žarković, N. (2005) · BioFactors · doi:10.1002/biof.5520240136 · Cited by 41
Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand (TRAIL)
Fulda, S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4471-6458-6_8 · Cited by 38
Yui, S., Osawa, Y., Ichisugi, T., & Morimoto‐Kamata, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/971409 · Cited by 38
McGary, C. T., Miele, M. E., & Welch, D. R. (1995) · PubMed · Cited by 35
Morimoto‐Kamata, R., Mizoguchi, S.-I., Ichisugi, T., & Yui, S. (2012) · Mediators of Inflammation · doi:10.1155/2012/456462 · Cited by 31
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
Self-citationThe Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Masucci, M. T., Minopoli, M., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01146 · Cited by 649
Metadata
- Authors
- Uribe-Querol, E., & Rosales, C.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-21
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W2214799754
- Cited by
- 422
- References
- 209
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.